282 related articles for article (PubMed ID: 30786001)
21. Functional analysis of rare anti-Müllerian hormone protein-altering variants identified in women with PCOS.
Meng L; McLuskey A; Dunaif A; Visser JA
Mol Hum Reprod; 2023 Apr; 29(5):. PubMed ID: 37004205
[TBL] [Abstract][Full Text] [Related]
22. Variants in the ACVR1 gene are associated with AMH levels in women with polycystic ovary syndrome.
Kevenaar ME; Themmen AP; van Kerkwijk AJ; Valkenburg O; Uitterlinden AG; de Jong FH; Laven JS; Visser JA
Hum Reprod; 2009 Jan; 24(1):241-9. PubMed ID: 18854405
[TBL] [Abstract][Full Text] [Related]
23. The phenotypic diversity in per-follicle anti-Müllerian hormone production in polycystic ovary syndrome.
Alebić MŠ; Stojanović N; Duhamel A; Dewailly D
Hum Reprod; 2015 Aug; 30(8):1927-33. PubMed ID: 26048913
[TBL] [Abstract][Full Text] [Related]
24. Polycystic ovary syndrome and anti-Müllerian hormone: role of insulin resistance, androgens, obesity and gonadotrophins.
Cassar S; Teede HJ; Moran LJ; Joham AE; Harrison CL; Strauss BJ; Stepto NK
Clin Endocrinol (Oxf); 2014 Dec; 81(6):899-906. PubMed ID: 25040369
[TBL] [Abstract][Full Text] [Related]
25. Accuracy of anti-Müllerian hormone and total follicles count to diagnose polycystic ovary syndrome in reproductive women.
Wongwananuruk T; Panichyawat N; Indhavivadhana S; Rattanachaiyanont M; Angsuwathana S; Techatraisak K; Pratumvinit B; Sa-Nga-Areekul N
Taiwan J Obstet Gynecol; 2018 Aug; 57(4):499-506. PubMed ID: 30122568
[TBL] [Abstract][Full Text] [Related]
26. Follicle-stimulating hormone suppressed excessive production of antimullerian hormone caused by abnormally enhanced promoter activity in polycystic ovary syndrome granulosa cells.
Li Y; Wei LN; Liang XY
Fertil Steril; 2011 Jun; 95(7):2354-8, 2358.e1. PubMed ID: 21514585
[TBL] [Abstract][Full Text] [Related]
27. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
Lauritsen MP; Bentzen JG; Pinborg A; Loft A; Forman JL; Thuesen LL; Cohen A; Hougaard DM; Nyboe Andersen A
Hum Reprod; 2014 Apr; 29(4):791-801. PubMed ID: 24435776
[TBL] [Abstract][Full Text] [Related]
28. Expression of anti-Müllerian hormone in letrozole rat model of polycystic ovary syndrome.
Du DF; Li XL; Fang F; Du MR
Gynecol Endocrinol; 2014; 30(12):885-9. PubMed ID: 25170777
[TBL] [Abstract][Full Text] [Related]
29. AMH and AMHR2 mutations: A spectrum of reproductive phenotypes across vertebrate species.
Mullen RD; Ontiveros AE; Moses MM; Behringer RR
Dev Biol; 2019 Nov; 455(1):1-9. PubMed ID: 31301298
[TBL] [Abstract][Full Text] [Related]
30. Associations of Polymorphisms in Anti-Müllerian Hormone (AMH Ile49Ser) and its Type II Receptor (AMHRII -482 A>G) on Reproductive Outcomes and Polycystic Ovary Syndrome: a Systematic Review and Meta-Analysis.
Pabalan N; Montagna E; Singian E; Tabangay L; Jarjanazi H; Barbosa CP; Bianco B
Cell Physiol Biochem; 2016; 39(6):2249-2261. PubMed ID: 27832628
[TBL] [Abstract][Full Text] [Related]
31. Assessment of FSHR, AMH, and AMHRII variants in women with polycystic ovary syndrome.
Czeczuga-Semeniuk E; Jarząbek K; Galar M; Kozłowski P; Sarosiek NA; Zapolska G; Wołczyński S
Endocrine; 2015 Apr; 48(3):1001-4. PubMed ID: 25012254
[No Abstract] [Full Text] [Related]
32. Anti-Mullerian hormone is increased in follicular fluid from unstimulated ovaries in women with polycystic ovary syndrome.
Das M; Gillott DJ; Saridogan E; Djahanbakhch O
Hum Reprod; 2008 Sep; 23(9):2122-6. PubMed ID: 18550512
[TBL] [Abstract][Full Text] [Related]
33. Substituting serum anti-Müllerian hormone for polycystic ovary morphology increases the number of women diagnosed with polycystic ovary syndrome: a community-based cross-sectional study.
Bell RJ; Islam RM; Skiba MA; Herbert D; Martinez Garcia A; Davis SR
Hum Reprod; 2021 Dec; 37(1):109-118. PubMed ID: 34741176
[TBL] [Abstract][Full Text] [Related]
34. Phenotypic variation in anti-Mullerian hormone (AMH) production per follicle in women with polycystic ovary syndrome (PCOS) and isolated polycystic ovarian morphology (PCOM): an observational cross-sectional study.
Bhide P; Kulkarni A; Dilgil M; Dhir P; Shah A; Gudi A; Homburg R
Gynecol Endocrinol; 2017 Oct; 33(10):801-806. PubMed ID: 28454499
[TBL] [Abstract][Full Text] [Related]
35. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E
Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740
[TBL] [Abstract][Full Text] [Related]
36. Age-stratified thresholds of anti-Müllerian hormone improve prediction of polycystic ovary syndrome over a population-based threshold.
Quinn MM; Kao CN; Ahmad AK; Haisenleder DJ; Santoro N; Eisenberg E; Legro RS; Cedars MI; Huddleston HG;
Clin Endocrinol (Oxf); 2017 Dec; 87(6):733-740. PubMed ID: 28681949
[TBL] [Abstract][Full Text] [Related]
37. Elevation of antimüllerian hormone in women with polycystic ovary syndrome undergoing assisted reproduction: effect of insulin.
Liu XY; Yang YJ; Tang CL; Wang K; Chen JJ; Teng XM; Ruan YC; Yang JZ
Fertil Steril; 2019 Jan; 111(1):157-167. PubMed ID: 30477916
[TBL] [Abstract][Full Text] [Related]
38. AMH and AMHR2 genetic variants in Chinese women with primary ovarian insufficiency and normal age at natural menopause.
Qin C; Yuan Z; Yao J; Zhu W; Wu W; Xie J
Reprod Biomed Online; 2014 Sep; 29(3):311-8. PubMed ID: 24912417
[TBL] [Abstract][Full Text] [Related]
39. [Anti-Mullerian hormone in the major phenotypes of polycystic ovary syndrome].
Parahuleva N; Pehlivanov B; Orbecova M; Uchikova E; Ivancheva H
Akush Ginekol (Sofiia); 2014; 53(5):22-7. PubMed ID: 25558667
[TBL] [Abstract][Full Text] [Related]
40. Elevated serum levels of anti-Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome.
Sahmay S; Atakul N; Aydogan B; Aydin Y; Imamoglu M; Seyisoglu H
Acta Obstet Gynecol Scand; 2013 Dec; 92(12):1369-74. PubMed ID: 23980726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
